ResMed Inc. Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ResMed Inc. treasury stock, value, acquired, cost method for the quarter ending 2026-06-30 was $201.63M.
- ResMed Inc. treasury stock, value, acquired, cost method for the quarter ending 2026-03-31 was $176.66M, a 135.46% increase year-over-year.
- ResMed Inc. treasury stock, value, acquired, cost method for the quarter ending 2025-12-31 was $177.00M, a 136.04% increase year-over-year.
- ResMed Inc. treasury stock, value, acquired, cost method for the quarter ending 2025-09-30 was $150.01M, a 199.99% increase year-over-year.
- ResMed Inc. treasury stock, value, acquired, cost method for fiscal 2026 was $705.30M, a 135.08% increase from fiscal 2025.
- ResMed Inc. treasury stock, value, acquired, cost method for fiscal 2025 was $300.02M, a 100.00% increase from fiscal 2024.
- ResMed Inc. treasury stock, value, acquired, cost method for fiscal 2024 was $150.01M.
- ResMed Inc. treasury stock, value, acquired, cost method for fiscal 2019 was $22.84M, a 57.54% decline from fiscal 2018.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2026-06-30 | $201.63M derived: 10-K 12 month − 3 quarters · filed 2026-08-13 | $705.30M 10-K · filed 2026-08-13 |
| 2026-03-31 | $176.66M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $177.00M 10-Q · filed 2026-05-01 | |
| 2025-09-30 | $150.01M 10-Q · filed 2026-05-01 | |
| 2025-06-30 | $300.02M 10-K · filed 2026-08-13 | |
| 2025-03-31 | $75.03M 10-Q · filed 2026-05-01 | |
| 2024-12-31 | $74.99M 10-Q · filed 2026-05-01 | |
| 2024-09-30 | $50.01M 10-Q · filed 2026-05-01 | |
| 2024-06-30 | $150.01M 10-K · filed 2026-08-13 | |
| 2024-03-31 | $50.00M 10-Q · filed 2025-04-24 | |
| 2023-12-31 | $50.01M 10-Q · filed 2025-04-24 | |
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-01 | $1.60B derived: sum of 4 quarters · filed 2021-08-17 |
| 2019-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-31 | $1.60B derived: sum of 4 quarters · filed 2021-08-17 |
| 2019-09-30 | $1.60B 10-Q · filed 2019-10-25 | $1.60B derived: sum of 4 quarters · filed 2021-08-17 |
| 2019-06-30 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-17 | $22.84M 10-K · filed 2021-08-17 |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-01 | $48.70M derived: sum of 4 quarters · filed 2020-08-13 |
| 2018-12-31 | -$45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-31 | $68.06M derived: sum of 4 quarters · filed 2020-08-13 |
| 2018-09-30 | $22.84M 10-Q · filed 2020-05-01 | $76.65M derived: sum of 4 quarters · filed 2020-08-13 |
| 2018-06-30 | $25.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | $53.80M 10-K · filed 2020-08-13 |
| 2018-03-31 | $19.36M 10-Q · filed 2019-05-03 | |
| 2017-12-31 | $8.54M 10-Q · filed 2019-05-03 | |
| 2016-06-30 | $102.06M 10-K · filed 2018-08-17 | |
| 2015-12-31 | $40.10M 10-Q · filed 2016-01-28 | |
| 2015-09-30 | $62.00M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $152.66M 10-K · filed 2017-08-04 | |
| 2015-03-31 | $20.30M 10-Q · filed 2016-04-29 | |
| 2014-12-31 | $33.50M 10-Q · filed 2016-01-28 | |
| 2014-09-30 | $42.90M 10-Q · filed 2015-10-27 | |
| 2014-06-30 | $208.08M 10-K · filed 2016-08-05 | |
| 2014-03-31 | $72.50M 10-Q · filed 2015-04-29 | |
| 2013-12-31 | $74.00M 10-Q · filed 2015-01-30 | |
| 2013-06-30 | $188.04M 10-K · filed 2015-08-07 | |
| 2012-06-30 | $391.25M 10-K · filed 2014-08-08 | |
| 2011-06-30 | $160.14M 10-K · filed 2013-08-13 | |
| 2010-06-30 | $135.86M 10-K · filed 2012-08-14 | |
| 2009-06-30 | $65.68M 10-K · filed 2011-08-17 |